FDA approved clinical trial can improve patient outcomes and decrease need to restent after AAA event.
EVAS is the next generation abdominal aortic aneurysm (AAA) therapy intended to treat more anatomies than currently approved endovascular stent graft devices, and is the only technology whose operating principle is centered around sealing the aneurysm sac. The device is not commercially available in the United States, and will only be available at a few selected clinical study sites throughout the U.S., for investigational use.
AAA is when the large blood vessel (aorta) that supplies blood to the abdomen, pelvis and legs becomes abnormally large or balloons outward. An abdominal aortic aneurysm can develop in anyone, but is most often seen in males over age 60 who have one or more risk factors, including emphysema, high blood pressure and/or cholesterol, obesity, and smoking. The larger the aneurysm, the more likely it is to rupture and break open. The outcome is usually good if an experienced surgeon repairs the aneurysm before it ruptures. When an abdominal aortic aneurysm ruptures, it is a true medical emergency. Less than 80 percent of patients survive a ruptured abdominal aneurysm.
“AAA is life-threatening. With appropriate intervention, either open abdominal aortic aneurysm repair or minimally invasive stent graft repair, and subsequent lifestyle adjustments, prognosis is good,” said Nikhil Kansal, MD, FACS, chief of the Center for Vascular and Endovascular Surgery at St. Elizabeth’s Medical Center. “As a minimally invasive surgeon with expertise in current stent technology, I see many patients that need to be re-treated in the years following the initial intervention. With the advanced technology of EVAS, our goal is to minimize the need for re-interventions and less post-procedure patient monitoring. This benefits the patient by decreasing the need for future hospitalizations, and may also diminish the need for multiple follow-up visits with the vascular surgeon.”
At the Center for Vascular and Endovascular Surgery, every patient meets with one of our highly skilled, board-certified surgeons.
Vascular disease comes in many different forms and our world class surgeons are experts at diagnosing and treating a wide-spectrum of vascular diseases.
St. Elizabeth’s Cosmetic Vein Center offers both cosmetic and therapeutic treatments of varicose veins and spider veins.
The Vascular Lab provides many types of testing and diagnostic services to help diagnosis a variety of vascular diseases.
Many patients who come to the Center for Vascular and Endovascular Surgery at St. Elizabeth's have a story to share about their care, recovery, and success after surgery or other treatments.
Center for Vascular and Endovascular Surgery
St. Elizabeth's Medical Center
736 Cambridge Street
Brighton, MA 02135